reference/11283461

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11283461

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study
endingPage	607
issn	1435-5922 0944-1174
issueIdentifier	6
pageRange	601-607
publicationName	Journal of Gastroenterology
startingPage	601
bibliographicCitation	Kurashige N, Hiramatsu N, Ohkawa K, Yakushijin T, Kiso S, Kanto T, Takehara T, Kasahara A, Doi Y, Yamada A, Oshita M, Mita E, Hagiwara H, Nagase T, Yoshihara H, Hayashi E, Imai Y, Kato M, Kashihara T, Hayashi N. Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B. Journal of Gastroenterology. 2009 Apr 22;44(6):601–7. doi: 10.1007/s00535-009-0038-6.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b48f82fa61b0c294be0875039caaeac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4ee8a21de260db15ec82716de88468b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7fc08f590efa465cdae06e12a7f75e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b19f6605e8e295ec4a82b80e2c56d11c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7924f4652aa28ffbc1c6966b3d42af6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0aeffb5775336e5968147d46cd077b53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e129ed15c3b11532f18c97f109c59a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_575b53c1d2c42df51dfbb98415c00923 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_adf6de6e0353593c3ffcb7bd7b9c8b1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a24755f4dd4eee7f1686f7a0ee0e1005 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97d32260403e5dd8961a9f64ec037d4b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f9a26e89da121bba02e9b8b96a7baed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c81d1b409114689fb850c5c29314130 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b477e625c70e53a58fcc7726036823da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c11814b74c4692f4577f67ca0addd7eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49927f83a01d031c8a9dd040b3ae3f00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a026330e1dbe6a7191ac690fc0b33455 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2da597bb880d0bd1100d9f1a7e289ad5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18f6f2f9f97bbb5cee8cdc74be53822c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6be7beaee2f1c197cd809cb90961dd4d
date	2009-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19387534 https://doi.org/10.1007/s00535-009-0038-6
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2560 https://portal.issn.org/resource/ISSN/1435-5922 https://portal.issn.org/resource/ISSN/0944-1174
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
discusses	http://id.nlm.nih.gov/mesh/M0571031 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0028682 http://id.nlm.nih.gov/mesh/M0278180 http://id.nlm.nih.gov/mesh/M0010216 http://id.nlm.nih.gov/mesh/M0000347 http://id.nlm.nih.gov/mesh/M0006695 http://id.nlm.nih.gov/mesh/M0010217
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60871 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID92729822 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134224745 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134222429 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204

Total number of triples: 58.